31
Growth Score in past quarter
pts
Heat Score 31 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Kaneq Bioscience Ltd, Montreal, is a spinout of Kaneq Pharma, a discovery and early development stage pharmaceutical company formed by
- Daniel Bouthillier: Founder, President & CEOPast Role: Merck, Executive Director of Research Administration and Planning
About the Company
Kaneq Bioscience Ltd, Montreal, is a spinout of Kaneq Pharma, a discovery and early development stage pharmaceutical company formed by former employees of the Merck Frosst Center for Therapeutic Research. This group has extensive drug discovery experience and has been intimately involved in the discovery of several marketed drugs plus novel
therapies for hypertension and diabetes currently in clinical development. The focus of Kaneq Pharma is the delivery of high value molecules for validated targets in the areas of metabolic disease and cancer.
